factual
Novo Nordisk Was Boring Until GLP-1 Success
Novo Nordisk was regarded as a boring European insulin company until it became roughly the 15th largest company in the world on the strength of GLP-1 drugs, which came from decades of scientists pushing a long-standing interest in the area.
factualpending
Speaker
AlexEvidence Quote
“Novo Nordisk was able to produce GLPs because they had this really long-standing interest in a specific area out of all diseases.”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...